The government has increased ceiling prices for BCG, Measles, and Measles-Rubella vaccines by approximately 21%. This decision follows a review after the Serum Institute of India appealed an earlier pricing order.

The revision aims to address the manufacturer's concerns and ensure continued availability of these vital public health vaccines easily.